Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin GB0009252882
Ticker GSK.L
Company GLAXOSMITHKLINE
Currency £
Price
Aware Investor Index (AII) 1,210.2436
Recommendation STRONG BUY
P/E 17.89
ROE 100.00 %
Capitalization 100,937,790,174 $
Dividend Yield 5.07 %
P/S 2.58
AII Position 7
P/E Position 229
ROE Position 27
Capitalization Position 103
Dividend Yield Position 89
Sales 30,186,000,000 £
10-Year Average Earnings 4,356,000,000 £
Shares Outstanding 4,941,000,000
Equity -68,000,000 £
Dividend per Share 0.8 £
Industry Pharmaceutical
Country Great Britain
GLAXOSMITHKLINE Investor Relations Web Site http://www.gsk.com/investors.html







Sales:

YEAR MONTH AMOUNT
2017 12 30,186,000,000.00 £
2016 12 27,889,000,000.00 £
2015 12 23,923,000,000.00 £
2014 12 23,006,000,000.00 £
2013 12 26,505,000,000.00 £

Earnings:

YEAR MONTH AMOUNT
2017 12 1,532,000,000.00 £
2016 12 912,000,000.00 £
2015 12 8,422,000,000.00 £
2014 12 2,756,000,000.00 £
2013 12 5,436,000,000.00 £
2012 12 4,499,000,000.00 £
2011 12 5,208,000,000.00 £
2010 12 2,961,000,000.00 £
2009 12 6,283,000,000.00 £
2008 12 5,551,000,000.00 £

Equity:

YEAR MONTH AMOUNT
2017 12 -68,000,000.00 £
2016 12 1,124,000,000.00 £
2015 12 5,114,000,000.00 £
2014 12 4,263,000,000.00 £
2013 12 7,812,000,000.00 £
2012 12 6,747,000,000.00 £
2011 12 8,827,000,000.00 £
2010 12 9,745,000,000.00 £
2009 12 10,742,000,000.00 £
2008 12 8,318,000,000.00 £

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 4,941,000,000
2016 12 4,909,000,000
2015 12 4,888,000,000
2014 12 4,865,000,000
2013 12 4,919,000,000
2012 12 4,913,000,000
2011 12 5,099,000,000
2010 12 5,128,000,000
2009 12 5,108,000,000
2008 12 5,226,000,000

 












Bloomberg News for GLAXOSMITHKLINE:



Google News for GLAXOSMITHKLINE:

Manville Messenger - 1 day ago
Can Glaxosmithkline Plc (GSK.L) Go The Extra Mile?
Watching the technicals on shares of Glaxosmithkline Plc (GSK.L), we have recently noted that the Chaikin Oscillator is above zero. Traders ...
Stocks Beat
Clal Insurance Enterprises Holdings LTD Has Increased Its Position ...
... 25/04/2018 – GLAXOSMITHKLINE GSK.L CEO SAYS HAS RULED OUT ANY INTEREST IN ACQUIRING SHIRE; 27/03/2018 – Novartis and ...
The NBO News
Glaxosmithkline Plc (GSK.L) Ichimoku Reading Shows Above the ...
Shares of Glaxosmithkline Plc (GSK.L) opened the last session at $1587.40, touching a high of $1601.808 and a low of $1581.00 , yielding a ...
Stocks Beat - 11 hours ago
GlaxoSmithKline plc (GSK.L) BTM Touches 1.006953 as Quant ...
GlaxoSmithKline plc (GSK.L) is yielding a market ratio of 0.050934. The book to market ratio is a relative valuation ratio which divides the book ...
Hoback Herald - 1 day ago
Glaxosmithkline Plc (GSK.L): Pulling the Layers Back For The ...
Reviewing the technicals on shares of Glaxosmithkline Plc (GSK.L), we have recently spotted the Chaikin Oscillator below zero. Traders may ...
Manville Messenger - 2 days ago
Choate Investment Advisors Has Decreased Its Holding in ...
Choate Investment Advisors decreased its stake in Glaxosmithkline Plc (GSK) by ... 25/04/2018 – GLAXOSMITHKLINE GSK.L NEW R&D HEAD ...
Manville Messenger - 2 days ago
As Prudential Finl (PRU) Market Value Rose, St Johns Investment ...
... in a Single-Pill Regimen; 25/04/2018 – GLAXOSMITHKLINE GSK.L CEO SAYS HAS RULED OUT ANY INTEREST IN ACQUIRING SHIRE; ...
Stocks Beat - 2 days ago
GlaxoSmithKline plc ($GSK.L): ROA 0.069517 Suggests Potential ...
GlaxoSmithKline plc (GSK.L) has an Return on Assets of 0.069517. The profit percentage of assets varies by industry, but in general, the higher ...
The NBO News
Lederer & Associates Investment Counsel Holds Position in Bunge ...
... 19/04/2018 – GLAXOSMITHKLINE PLC GSK.L – LANDMARK IMPACT STUDY PUBLISHED IN NEJM SHOWS SIGNIFICANT BENEFITS OF ...
The EN Herald
John G Ullman & Associates Holding in Glaxosmithkline Plc (GSK ...
19/04/2018 – GLAXOSMITHKLINE PLC GSK.L – LANDMARK IMPACT STUDY PUBLISHED IN NEJM SHOWS SIGNIFICANT BENEFITS OF ...


Back